Clinical Trial Update: Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety of pemetrexed plus cisplatin in malignant pleural mesothelioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• CISPLATIN (cisplatin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Malignant Pleural Mesothelioma | Phase 2 | Status: COMPLETED